Stakeholder Insight: The Screening and Diagnosis of Breast Cancer

Introduction

In this Analysis, which utilizes data from Datamonitor’s pioneering Breast Cancer Insight study, the principles of mammography screening, and diagnostic and biological testing are explained and the relative merits and disadvantages of each are debated. 

Scope

Use of diagnostic investigations by physicians is investigated, using data from Datamonitor’s Breast Cancer Insight survey 

Datamonitor asks whether physicians routinely test the HER-2 status of their breast cancer patients; physicians' responses are presented and analyzed. 

Datamonitor explores the degree to which cost, effectiveness and availability were influencing the way in which HER-2 status is determined. 

Report Highlights

An analysis of Datamonitor’s Breast Cancer Insight survey results, which interviewed 580 leading breast cancer specialists across Europe, the US and Japan, in 2002, provides insight into the attitudes about, and requirements for, formal screening procedures and diagnostic techniques. 

Reasons to Purchase

Plan new drug development to meet patient management requirements 

Explore the reasons, rational and emotional, behind cancer specialists' decisions 

Predict future trends and perception in the treatment of breast cancer patients 

Publisher: Datamonitor Oncology Reports 

To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/Datamonitor_Oncology.html#a259